Replies to post #123150 on Biotech Values

[genisi]

Think the FDA will probably ask for another trial in that subset. Another question/problem is what will it take to find early AD patients - PIB brain imaging? CSF phoshpo-Tau levels? these tests carry logistic and economic implications.